Track market-moving stories before they get noisy

ODDITY (NASDAQ:ODD) shares jumped 14% on Wednesday after the company posted second-quarter results that topped Wall Street estimates and issued a stronger-than-expected full-year profit outlook.

The consumer tech company reported revenue of $181 million for the quarter, beating estimates of $178 million but down 25% from a year earlier. Adjusted earnings per share came in at $0.20, ahead of the $0.16 estimate, while adjusted EBITDA reached $13 million, more than the $8.8 million analysts had projected.

For fiscal 2026, ODDITY guided adjusted EBITDA of $30 million to $32 million, well above the $10.7 million estimate, with revenue expected to decline 19% year-over-year. For the third quarter, the company forecast adjusted EBITDA of $18 million to $20 million against estimates of $6.3 million, with revenue seen down 5% from a year earlier.

Gross margin was 68.7%, down 360 basis points from a year ago. Net income for the quarter was $13 million, and the company held $561 million in cash, cash equivalents and investments.

"We made progress during the quarter, including strong results for both SpoiledChild and METHODIQ," said Oran Holtzman, ODDITY co-founder and CEO. "We remain hopeful that IL MAKIAGE is on track to achieve normalization and we continue to work in close partnership with our largest advertising partner to solve the technical issue."

ODDITY is a consumer tech company that uses AI and data science to build digital-first beauty and wellness brands, including IL MAKIAGE, SpoiledChild and METHODIQ, serving over 70 million users.

No Investment Advice

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Oddity Tech (ODD - Free Report) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.92 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +66.67%. A quarter ago, it was expected that this online retailer of cosmetics and beauty products would post a loss of $0.04 per share when it actually produced a loss of $0.17, delivering a surprise of -325%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Oddity Tech, which belongs to the Zacks Internet - Software industry, posted revenues of $180.52 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 3.27%. This compares to year-ago revenues of $241.14 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Oddity Tech shares have lost about 67.6% since the beginning of the year versus the S&P 500's gain of 12.1%.

What's Next for Oddity Tech?While Oddity Tech has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Oddity Tech was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.10 on $118.35 million in revenues for the coming quarter and $0.06 on $619.4 million in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Internet - Software is currently in the top 35% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, Penguin Solutions, Inc. (PENG - Free Report) , has yet to report results for the quarter ended August 2026.

This company is expected to post quarterly earnings of $0.75 per share in its upcoming report, which represents a year-over-year change of +74.4%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Penguin Solutions, Inc.'s revenues are expected to be $512.5 million, up 51.7% from the year-ago quarter.

Second quarter net revenue of $181 million, down approximately 25% year-over-yearSecond quarter adjusted EBITDA of $13 millionSecond quarter net income of $13 million and second quarter adjusted net income of $11 millionStrong liquidity position including cash, cash equivalents and investments of $561 million, and aggregate credit facilities of $350 million which remain undrawn NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (NASDAQ: ODD) today announced its financial results for the second quarter ended June 30, 2026.

“We made progress during the quarter, including strong results for both SpoiledChild and METHODIQ,” said Oran Holtzman, ODDITY co-founder and CEO. “We remain hopeful that IL MAKIAGE is on track to achieve normalization and we continue to work in close partnership with our largest advertising partner to solve the technical issue.”

ODDITY achieved key objectives during the second quarter, including:

Double-digit revenue growth for SpoiledChild during the second quarter. SpoiledChild is on track to grow at least 35% compared to 2025 and approach $350 million of net revenue in 2026.Strong early results for METHODIQ, which we now expect to deliver first-year net revenue ahead of SpoiledChild’s first year.Ongoing development and expansion of the ODDITY Labs molecule discovery platform.Enhancing our capital structure, including repurchasing $80 million of our Class A ordinary shares and retiring $50 million of our zero coupon 2030 exchangeable notes, while maintaining a strong liquidity position. “So far in the third quarter, we are seeing an improved year-over-year net revenue trend, driven by growth at SpoiledChild and METHODIQ and a moderating impact from the IL MAKIAGE account dislocation,” said Lindsay Drucker Mann, ODDITY Global CFO. “As a result, we now expect third quarter net revenue to decline approximately 5% year-over-year, a meaningful sequential improvement from the first half.”

Update on IL MAKIAGE Account Dislocation

ODDITY continues to work closely with its largest advertising partner to solve the advertising algorithm dislocation at IL MAKIAGE. Since its last earnings call, ODDITY has implemented various tests and strategies to address signal distortion and retrain the algorithm. ODDITY continues to believe the dislocation is technical in nature and solvable, and is encouraged by the progress it is making toward normalization.

Share Buybacks

ODDITY repurchased approximately 5.6 million Class A ordinary shares during the second quarter for approximately $80 million under the $200 million share buyback plan authorized in March 2026 (the “2026 Buyback Plan”). On a year-to-date basis, ODDITY has repurchased approximately 11.7 million Class A ordinary shares for approximately $163 million, including approximately $50 million of repurchases completed before the adoption of the 2026 Buyback Plan under ODDITY’s prior share buyback authorization, reducing total ordinary shares outstanding by approximately 20%. Approximately $87 million remains under the 2026 Buyback Plan, subject to market conditions and legal and regulatory constraints.

Exchangeable Note Repurchase

In June 2026, ODDITY repurchased and retired $50 million aggregate principal amount of its 0% exchangeable notes due 2030 for approximately $35 million, leaving approximately $550 million aggregate principal amount outstanding.

Second Quarter Fiscal 2026 Financial Highlights:

Results for the second quarter ended June 30, 2026 are presented below in comparison to the second quarter ended June 30, 2025.

Net revenue was $181 million compared to $241 million in the second quarter of 2025, a decrease of 25%.Gross profit was $124 million compared to $174 million in the second quarter of 2025; gross margin was 68.7% compared to 72.3%.Net income was $13 million compared to $49 million in the second quarter of 2025.Adjusted net income was $11 million compared to $57 million in the second quarter of 2025.Adjusted EBITDA was $13 million compared to $70 million in the second quarter of 2025.Diluted earnings per share was $0.24 compared to $0.79 in the second quarter of 2025.Adjusted diluted earnings per share was $0.20 compared to $0.92 in the second quarter of 2025.Cash, cash equivalents, and investments were $561 million as of June 30, 2026. Financial results have been rounded to the nearest million, unless indicated otherwise.

The table below sets forth our actual results for the three months ended June 30, 2026 and the low and high end of our guidance range regarding our results for the second quarter of 2026 as issued on June 2, 2026.

 Three months ended June 30, 2026 Actual
ResultsGuidance
Low EndGuidance
High EndNet Revenue-25%-30%-25%Adjusted EBITDA$13 million$8 million$10 million
Financial Outlook:

ODDITY is providing the following guidance for the third quarter ending September 30, 2026:

Net revenue to decline by approximately 5% year-over-yearAdjusted EBITDA between $18 million and $20 million ODDITY is providing the following guidance for the full year ending December 31, 2026:

Net revenue to decline by approximately 19% year-over-yearAdjusted EBITDA between $30 million and $32 million Adjusted EBITDA, Adjusted net income, and Adjusted diluted earnings per share are non-GAAP financial measures. Please see the sections titled “Non-GAAP Financial Measures” and “Reconciliation of GAAP to Non-GAAP Measures” below for more information regarding ODDITY’s use of non-GAAP financial measures and reconciliations to the most directly comparable GAAP measures. ODDITY has not provided a quantitative reconciliation of its Adjusted EBITDA outlook to the corresponding net income measure because the quantification of certain items included in the calculation of GAAP net income cannot be calculated or predicted at this time without unreasonable efforts. ODDITY is unable to address the probable significance of the unavailable reconciling items, which could have a potentially unpredictable, and potentially significant, impact on its future GAAP financial results.

The financial outlook figures presented above are forward-looking statements that are subject to a variety of assumptions and estimates. Actual results may differ materially from ODDITY’s financial outlook as a result of, among other things, the factors described under “Forward-Looking Statements” below.

Conference Call Details:

A conference call to discuss ODDITY’s Q2 2026 financial and business results and outlook is scheduled for today, September 9, 2026, at 8:30 a.m. ET. To participate, please dial 1-877-407-9208 (US) or 1-201-493-6784 (international). To access the call, please reference the company name and call title: ODDITY Second Quarter 2026 Earnings Call. A webcast of the call will be accessible on the Investors section of ODDITY’s website at https://investors.oddity.com. A recording will be available shortly after the conclusion of the call. To access the replay, please dial 1-844-512-2921 (US) or 1-412-317-6671 (international). The access code for the replay is 13761986. An archive of the webcast will be available on the Investors section of ODDITY’s website for seven days following the call.

Non-GAAP Financial Measures:

In addition to the GAAP financial measures set forth in this press release, ODDITY has included the following non-GAAP financial measures: Adjusted EBITDA, Adjusted net income, Adjusted diluted earnings per share, and free cash flow. ODDITY believes these non-GAAP financial measures provide useful supplemental information to management and investors to help evaluate ODDITY’s business, measure its performance, identify trends, prepare financial projections, and make business decisions.

ODDITY defines “Adjusted EBITDA” as net income (loss) before financial income, net, taxes on income, and depreciation and amortization as further adjusted to exclude share-based compensation expense and certain unusual or non-recurring items. ODDITY believes Adjusted EBITDA is useful for financial and operational decision-making and as a means to evaluate period-to-period comparisons. By excluding certain items that may not be indicative of its recurring core operating results, ODDITY believes that Adjusted EBITDA provides meaningful supplemental information regarding its performance. In addition, Adjusted EBITDA is widely used by investors and securities analysts to measure a company’s operating performance without regard to items such as depreciation and amortization, interest expense, and interest income, which can vary substantially from company to company depending on their financing and capital structures and the method by which their assets were acquired.

ODDITY defines “Adjusted net income” as net income (loss) adjusted for the impact of share-based compensation, certain unusual or non-recurring items, one-time tax gains/losses and the tax effect of non-GAAP adjustments. In addition, ODDITY defines “Adjusted diluted earnings per share” as Adjusted net income divided by diluted shares outstanding. ODDITY believes the presentations of Adjusted net income and Adjusted diluted earnings per share are useful because they are frequently used by analysts, investors and other interested parties to evaluate companies in our industry. Further, ODDITY believes these measures are helpful in highlighting trends in our operating results, because they exclude the impact of items that are outside the control of management or not reflective of our ongoing operations and performance.

ODDITY defines “free cash flow” as net cash (used in) provided by operating activities less purchase of property and equipment.

ODDITY’s non-GAAP financial measures should be considered in addition to, not as a substitute for or in isolation from, its financial results prepared in accordance with U.S. GAAP. Other companies, including companies in our industry, may calculate these measures differently or not at all, which reduces their usefulness as comparative measures.

Reconciliations of non-GAAP financial measures to the most directly comparable GAAP measures are included with the financial tables at the end of this release under the heading “Reconciliation of GAAP to Non-GAAP Measures.” 

Forward-Looking Statements:

Certain statements in this press release may constitute “forward-looking” statements and information, within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 that relate to our current expectations and views of future events. In some cases, these forward-looking statements can be identified by words or phrases such as “aim,” “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “goal,” “hope,” “intend,” “may,” “objective,” “plan,” “potential,” “predict,” “project,” “shall,” “should,” “target,” “will,” “seek,” or similar words. The absence of these words does not mean that a statement is not forward-looking. These forward-looking statements address various matters, including ODDITY’s business strategy, market opportunity, ability to deliver superior products and experiences, ability to remedy the dislocation in our customer acquisition costs, potential long-term success and ODDITY’s outlook for the third quarter of 2026 and the full year ending December 31, 2026. These forward-looking statements are subject to risks, uncertainties and assumptions, some of which are beyond our control. In addition, these forward-looking statements reflect our current views with respect to future events and are not a guarantee of future performance. Actual outcomes may differ materially from the information contained in the forward-looking statements as a result of a number of factors, including, without limitation, the following: our ability to maintain the value of our brands; our ability to anticipate and respond to market trends and changes in consumer preferences; our ability to cost-effectively attract new customers (including by responding effectively to changes to algorithm-based bidding systems on key advertising platforms), retain existing customers and maintain or increase sales to those customers; our ability to maintain a strong base of engaged customers and content creators; the loss of suppliers or shortages or disruptions in the supply of raw materials or finished products; our ability to accurately forecast customer demand, manage our inventory, and plan for future expenses; our future rate of growth; competition; the fluctuating cost of raw materials; the illegal distribution and sale by third parties of counterfeit versions of our products or the unauthorized diversion by third parties of our products; changes in, or disruptions to, our shipping arrangements; our ability to manage our growth effectively; a general economic downturn or sudden disruption in business conditions; our ability to successfully introduce and effectively market new brands, or develop and introduce new, innovative, and updated products; foreign currency fluctuations; product returns; our ability to execute on our business strategy; our ability to maintain a high level of customer satisfaction; our ability to comply with and adapt to changes in laws and regulatory requirements applicable to our business, including with respect to regulation of the internet and e-commerce, evolving AI-technology related laws, tax laws, the anti-corruption, trade compliance, anti-money laundering, and terror finance and economic sanctions laws and regulations, consumer protection laws, and data privacy and security laws; failure of our products to comply with quality standards and risks related to product liability claims; trade restrictions; existing and potential tariffs; any data breach or other security incident of our information technology systems, or those of our third-party service providers or cyberattacks; risks related to online transactions and payment methods; any failure to obtain, maintain, protect, defend, or enforce our intellectual property rights; conditions in Israel and the Middle East generally, including as a result of geopolitical conflict; the concentration of our voting power as a result of our dual class structure; our status as a foreign private issuer; and other risk factors set forth in the section titled “Risk Factors” in our Annual Report on Form 20-F filed with the Securities and Exchange Commission on March 17, 2026, and other documents filed with or furnished to the SEC. These statements reflect management’s current expectations regarding future events and operating performance and speak only as of the date of this press release. You should not put undue reliance on any forward-looking statements. Except as required by applicable law, we undertake no obligation to update or revise publicly any forward-looking statements.

About ODDITY:

ODDITY is a consumer tech company that builds and scales digital-first brands to disrupt the offline-dominated beauty and wellness industries. The company serves over 70 million users with its AI-driven online platform, deploying data science to identify consumer needs, and developing solutions in the form of beauty and wellness products. ODDITY owns IL MAKIAGE, SpoiledChild, and METHODIQ. The company operates with business headquarters in New York City, an R&D center in Tel Aviv, Israel, and a biotechnology lab in Boston.

Contacts:

Press:

[email protected]

Investor:

[email protected]

ODDITY TECH LTD.CONSOLIDATED STATEMENTS OF INCOMEU.S. dollar in thousands (except per share data)

  Three months ended
June 30, Six months ended
June 30,  2026
 2025
 2026
 2025
           Unaudited UnauditedNet revenue $180,517  $241,140  $378,457  $509,216          Cost of revenue  56,571   66,788   116,541   134,016          Gross profit  123,946   174,352   261,916   375,200          Selling, general and administrative  125,206   117,258   288,666   275,441          Operating (loss) income  (1,260)   57,094   (26,750)   99,759          Financial (income), net  (16,533)   (2,493)   (21,839)   (5,140)          Income (loss) before taxes on income  15,273   59,587   (4,911)   104,899          Taxes on income  2,383   10,302   3,560   17,783          Net income (loss) $12,890  $49,285  $(8,471)  $87,116 Weighted-average number of shares – basic (thousands)  47,683   56,822   51,974   56,413 Weighted-average number of shares – diluted (thousands)  54,084   62,335   51,974   61,329          Earnings (loss) per share attributable to Class A and Class B Ordinary shareholders:        Basic $0.27  $0.87  $(0.16)  $1.54 Diluted $0.24  $0.79  $(0.16)  $1.42  ODDITY TECH LTD.CONSOLIDATED BALANCE SHEETSU.S. dollar in thousands

  June 30,
 December 31,
  2026
 2025
  (Unaudited)
 (Audited)
ASSETS      CURRENT ASSETS:      Cash and cash equivalents $167,274  $402,209 Marketable securities  25,880   11,170 Trade receivables  12,129   16,902 Inventories  152,170   135,181 Prepaid expenses and other current assets  33,218   36,336        Total current assets  390,671   601,798        LONG-TERM ASSETS:      Marketable securities  368,008   362,571 Property, plant and equipment, net  10,044   10,864 Deferred tax asset, net  28,811   27,693 Intangible assets, net  48,462   43,582 Goodwill  64,904   64,904 Operating lease right-of-use assets  19,918   22,311 Other assets  4,305   4,069        Total long-term assets  544,452   535,994        Total assets $935,123  $1,137,792  ODDITY TECH LTD.CONSOLIDATED BALANCE SHEETSU.S. dollar in thousands

  June 30, December 31,
  2026
 2025
  (Unaudited) (Audited)
LIABILITIES AND SHAREHOLDERS’ EQUITY     CURRENT LIABILITIES:     Trade payables $63,076  $75,957 Other accounts payable and accrued expenses  44,347   32,869 Operating lease liabilities, current  5,764   6,002       Total current liabilities  113,187   114,828       LONG-TERM LIABILITIES:     Operating lease liabilities, non-current  16,231   17,463 Exchangeable Note  537,246   584,368 Other long-term liabilities  25,187   24,638       Total liabilities  691,851   741,297       SHAREHOLDERS’ EQUITY:     Class A Ordinary shares  11   15 Class B Ordinary shares  3   3 Additional paid-in capital  (65,340)   77,571 Accumulated other comprehensive income  3,055   4,892 Retained earnings  305,543   314,014       Total shareholders’ equity  243,272   396,495       Total liabilities and shareholders’ equity $935,123  $1,137,792  ODDITY TECH LTD.

CONSOLIDATED STATEMENTS OF CASH FLOWS
U.S. dollar in thousands  Six months ended
June 30,  2026
 2025
  (Unaudited)Cash flows from operating activities:    Net (loss) income $(8,471)  $87,116 Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:    Depreciation and amortization  7,501   5,308 Share-based compensation  17,887   16,853 Deferred income taxes  (718)   (1,109) Amortization of debt issuance costs  1,708   - Gain on repurchase of 0% exchangeable senior notes due 2030 ("exchangeable notes")  (13,539)   - Change in trade receivables  4,773   (1,578) Change in prepaid expenses and other receivables  2,827   (422) Change in inventories  (16,989)   5,576 Change in trade payables  (12,881)   (7,315) Change in other accounts payable and accrued expenses  13,192   (3,191) Change in operating lease right-of-use assets  4,018   3,911 Change in operating lease liability  (3,094)   (2,872) Other  (2,159)   (893)      Net cash (used in) provided by operating activities $(5,945)  $101,384      Cash flows from investing activities:    Purchase of property and equipment  (1,559)   (1,951) Capitalization of software development costs and investment in other intangible assets  (8,053)   (3,290) Investment in marketable securities, net  (21,475)   (81,224) Maturities in short-term deposits  -   47,000 Other investing activities  -   (151)      Net cash used in investing activities  (31,087)   (39,616)      Cash flows from financing activities:    Proceeds from issuance of exchangeable notes, net of issuance costs  -   583,500 Repurchase of exchangeable notes  (35,125)   - Purchase of capped calls  -   (50,592) Proceeds from exercise of options  27   11,444 Repurchase and retirement of Class A ordinary shares  (162,778)   -      Net cash (used in) provided by financing activities  (197,876)   544,352      Effect of exchange rate fluctuations on cash and cash equivalents  (75)   432      Net (decrease) increase in cash, cash equivalents and restricted cash  (234,983)   606,552 Cash, cash equivalents and restricted cash at the beginning of the period  402,279   50,347      Cash, cash equivalents and restricted cash at the end of the period $167,296  $656,899  ODDITY TECH LTD.Reconciliation of GAAP to Non-GAAP MeasuresU.S. dollar in thousands (except per share data)  Three months ended
June 30,
 Six months ended
June 30,
  2026
 2025
 2026
 2025
           (Unaudited) (Unaudited)Reconciliation of Net Income (Loss) and Adjusted EBITDA        Net income (loss) $12,890  $49,285  $(8,471)  $87,116 Financial (income), net  (16,533)   (2,493)   (21,839)   (5,140) Taxes on income  2,383   10,302   3,560   17,783 Depreciation and amortization  3,232   2,653   7,501   5,308 Share-based compensation  9,786   9,769   17,887   16,853 Other adjustments1  1,115   -   7,199   -          Adjusted EBITDA $12,873  $69,516  $5,837  $121,920          Reconciliation of Net Income (Loss) and Adjusted Net Income                          Net income (loss) $12,890  $49,285  $(8,471)  $87,116 Share-based compensation  9,786   9,769   17,887   16,853 Other adjustments2  (12,424)   -   (6,340)   - Tax adjustments3  485   (1,974)   (2,123)   (5,080)          Adjusted net income $10,737  $57,080  $953  $98,889          Diluted earnings (loss) per share $0.24  $0.79  $(0.16)  $1.42 Impact of adjustments  (0.04)   0.13   0.18   0.19          Adjusted diluted earnings per share4 $0.20  $0.92  $0.02  $1.61  Reconciliation of net cash (used in) provided by operating activities to free cash flow

  Six months ended
June 30  2026
 2025
  (Unaudited)Net cash (used in) provided by operating activities $(5,945)  $101,384 Purchase of property and equipment  (1,559)   (1,951)      Free cash flow $(7,504)  $99,433  1 Represents costs of certain legal matters and employee actions outside the ordinary course of business.
2 Represents costs of certain legal matters and employee actions outside the ordinary course of business and, in the second quarter of 2026, a $13.539 million gain on repurchases of our exchangeable notes.
3 Represents the tax impact of (a) the reconciling items above and (b) other discrete tax items in 2025.
4 For the first half of 2026, the Weighted-average number of shares – diluted (thousands) used to calculate Adjusted diluted earnings per share is 55,927.

ODDITY TECH LTD.Supplemental Financial InformationU.S. dollar in thousandsCash, cash equivalents, and investments  June 30,
 December 31,
  2026
 2025
  (Unaudited)  (Audited)        Cash, restricted cash, and cash equivalents $167,296  $402,279 Marketable securities  393,888   373,741        Total cash and investments $561,184  $776,020  Net revenue by sales channel

  Three months ended Six months ended  June 30,June 30,  2026
 2025
 2026
 2025
  (Unaudited) (Unaudited)Online direct-to-consumer $174,058  $235,161  $367,113  $496,214 Percent of net revenue  96%   98%   97%   97%          Other (Israel retail, marketing affiliates) $6,459  $5,979  $11,344  $13,002 Percent of net revenue  4%   2%   3%   3%          Net revenue $180,517  $241,140  $378,457  $509,216  Note: ODDITY does not sell to resellers or distributors. Online direct-to-consumer revenues are generated directly by ODDITY through its online platform only (i.e., ILMAKIAGE.com, SpoiledChild.com, and METHODIQ.com). All revenue in Israel, including revenue generated in stores, online, and from beauty academies, is included in Other.

Strong growth from Vyepti and focused commercial execution drive total revenue growth of +16% CER (+13% CER underlying) in H1 2026

Posted by Defense World Staff on Aug 9th, 2026

Empowered Funds LLC acquired a new position in ODDITY Tech Ltd. (NASDAQ:ODD – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 95,323 shares of the company’s stock, valued at approximately $1,275,000. Empowered Funds LLC owned approximately 0.17% of ODDITY Tech at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Wexford Capital LP purchased a new stake in shares of ODDITY Tech during the third quarter worth about $40,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in ODDITY Tech by 134.8% in the 3rd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 1,134 shares of the company’s stock worth $69,000 after purchasing an additional 651 shares in the last quarter. USS Investment Management Ltd grew its position in ODDITY Tech by 5.3% during the 4th quarter. USS Investment Management Ltd now owns 13,753 shares of the company’s stock worth $552,000 after purchasing an additional 695 shares during the last quarter. California State Teachers Retirement System increased its stake in ODDITY Tech by 2.0% during the 4th quarter. California State Teachers Retirement System now owns 43,532 shares of the company’s stock valued at $1,749,000 after purchasing an additional 870 shares in the last quarter. Finally, Entropy Technologies LP raised its holdings in shares of ODDITY Tech by 10.0% in the third quarter. Entropy Technologies LP now owns 9,900 shares of the company’s stock worth $617,000 after buying an additional 900 shares during the last quarter. 35.88% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes Several equities research analysts have recently commented on the stock. Needham & Company LLC reiterated a “hold” rating on shares of ODDITY Tech in a research note on Tuesday, June 2nd. Jefferies Financial Group reaffirmed a “hold” rating and set a $10.25 price target on shares of ODDITY Tech in a research report on Tuesday, June 2nd. Morgan Stanley dropped their price target on ODDITY Tech from $16.00 to $10.00 and set an “equal weight” rating on the stock in a research note on Wednesday, June 3rd. Barclays cut their price objective on ODDITY Tech from $13.00 to $8.00 and set an “underweight” rating on the stock in a report on Wednesday, June 3rd. Finally, Wall Street Zen downgraded ODDITY Tech from a “sell” rating to a “strong sell” rating in a report on Saturday, April 18th. Nine research analysts have rated the stock with a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Reduce” and an average price target of $25.39.

Check Out Our Latest Stock Report on ODD

ODDITY Tech Stock Performance NASDAQ ODD opened at $14.12 on Friday. The firm has a market capitalization of $812.96 million, a P/E ratio of 17.87 and a beta of 2.38. The stock has a 50-day simple moving average of $14.32 and a two-hundred day simple moving average of $17.35. The company has a debt-to-equity ratio of 1.96, a quick ratio of 2.86 and a current ratio of 4.06. ODDITY Tech Ltd. has a fifty-two week low of $9.25 and a fifty-two week high of $64.23.

ODDITY Tech (NASDAQ:ODD – Get Free Report) last issued its earnings results on Tuesday, June 2nd. The company reported ($0.17) EPS for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.13). The company had revenue of $197.94 million during the quarter, compared to analysts’ expectations of $187.87 million. ODDITY Tech had a return on equity of 15.38% and a net margin of 6.97%.The firm’s quarterly revenue was down 26.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.69 EPS. On average, equities analysts forecast that ODDITY Tech Ltd. will post -0.55 earnings per share for the current year.

Insider Buying and Selling In other news, CFO Mann Lindsay Drucker sold 11,473 shares of the firm’s stock in a transaction that occurred on Wednesday, August 5th. The shares were sold at an average price of $15.10, for a total transaction of $173,242.30. Following the sale, the chief financial officer owned 104,492 shares of the company’s stock, valued at $1,577,829.20. This trade represents a 9.89% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders sold 130,678 shares of company stock valued at $1,956,201.

ODDITY Tech Profile (Free Report)

Oddity Tech Ltd. operates as a consumer tech company that builds digital-first brands for the beauty and wellness industries in the United States and internationally. It serves consumers worldwide through its AI-driven online platform, which uses data science, machine learning, and computer vision capabilities to identify consumer needs, and develop solutions in the form of beauty and wellness products. The company sells beauty, hair, and skin products under the IL MAKIAGE and SpoiledChild brands.

Read More Five stocks we like better than ODDITY Tech Quantum Earnings Week: Winners and Losers Are Finally Emerging Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish Want to see what other hedge funds are holding ODD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ODDITY Tech Ltd. (NASDAQ:ODD – Free Report).

Receive News & Ratings for ODDITY Tech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ODDITY Tech and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINE9,674 Shares in Granite Construction Incorporated $GVA Acquired by Empowered Funds LLC

NEXT HEADLINE »California State Teachers Retirement System Buys 12,878 Shares of Whirlpool Corporation $WHR

Fosun International Wins Three Awards from Global Banking and Finance Review, Gaining International Recognition for its ESG Performance, Corporate

Fosun International Garners Five Awards from Corporate Governance Asia PR Newswire HONG KONG, July 2, 2026

Oddity Tech is downgraded from buy to hold due to unresolved customer acquisition cost headwinds and weak first-order growth. Q1 2026 revenue declined 26% y/y, with first orders down ~50% and margins deteriorating; Q2 guidance suggests continued revenue contraction. The investment thesis now hinges on whether CPA normalization is temporary or structural, as elevated CPA undermines the core acquisition engine.

San Francisco, California--(Newsfile Corp. - May 9, 2026) - Hagens Berman, a global shareholder rights law firm, updates investors in ODDITY Tech Ltd. (NASDAQ: ODD) regarding the pending securities class action lawsuit following a massive 49% stock collapse. The firm reminds investors that the deadline to move for Lead Plaintiff is May 11, 2026.

SUBMIT YOUR LOSSES TO HAGENS BERMAN NOW

The ODD Securities Class Action: When Did ODDITY Know About the Dislocation?

The lawsuit against ODDITY, a consumer tech company that uses AI to sell beauty products, alleges the company misrepresented the stability of its digital operating model. While ODDITY repeatedly assured investors that its AI platform would sustain high growth and attractive margins, it allegedly failed to disclose a critical disruption.

On February 25, 2026, ODDITY admitted it had experienced a dislocation in its primary advertising account due to algorithm changes by its largest partner. This change diverted ODDITY's ads to lower-quality auctions at abnormally high costs, causing:

Spiking Customer Acquisition Costs (CAC): Advertising efficiency plummeted, directly impacting margins.Severe Revenue Contraction: The company projected a staggering 30% year-over-year revenue decline for Q1 2026.Delayed Disclosure: During an earnings call, management admitted they "observed that something was different in the second half of 2025," yet they continued to issue optimistic growth guidance as late as November 2025.Wall Street Reaction and Market Impact

The disclosure triggered a massive selloff. ODDITY's shares fell $14.28 per share, or nearly 50%, to close at $14.74 on February 25, 2026, wiping out more than $600 million in market capitalization. In the wake of this news, major Wall Street firms, including JPMorgan and Bank of America, cut their ratings on the stock.

"We are investigating whether ODDITY knowingly issued false statements during the second half of 2025 while privately watching its primary growth engine fail," said Reed Kathrein, the Hagens Berman partner leading the investigation.

Lead Plaintiff Deadline: May 11, 2026

Investors who purchased ODDITY securities between February 26, 2025, and February 24, 2026, and suffered losses, have until May 11, 2026, to seek a lead role in the litigation.

Report Your ODD Investment Losses Now Visit: www.hbsslaw.com/cases/oddity Email: [email protected] Call 844-916-0895Whistleblowers: Persons with non-public information regarding ODDITY should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

# # #

About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman's team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

Contact:
Reed Kathrein, 844-916-0895

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/296656

Source: Hagens Berman Sobol Shapiro LLP

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

New York, New York--(Newsfile Corp. - May 10, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ODDITY Tech Ltd. (NASDAQ: ODD) between February 26, 2025 and February 24, 2026, inclusive (the "Class Period"), of the important May 11, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Oddity securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Oddity class action, go to https://rosenlegal.com/submit-form/?case_id=27381 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 11, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) due to an algorithm change by Oddity's largest advertising partner, Oddity's advertisements were being diverted to lower quality auctions at abnormally high costs; (2) the foregoing significantly increased Oddity's customer acquisition costs, thereby negatively impacting Oddity's business and financial prospects; (3) accordingly, defendants overstated the overall strength, stability, and sustainability of Oddity's digital operating model and/or market position; and (4) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Oddity class action, go to https://rosenlegal.com/submit-form/?case_id=27381 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/296711

Source: The Rosen Law Firm PA

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

NEW YORK, May 10, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ODDITY Tech Ltd. (NASDAQ: ODD) between February 26, 2025 and February 24, 2026, inclusive (the “Class Period”), of the important May 11, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Oddity securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Oddity class action, go to https://rosenlegal.com/submit-form/?case_id=27381 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 11, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) due to an algorithm change by Oddity’s largest advertising partner, Oddity’s advertisements were being diverted to lower quality auctions at abnormally high costs; (2) the foregoing significantly increased Oddity’s customer acquisition costs, thereby negatively impacting Oddity’s business and financial prospects; (3) accordingly, defendants overstated the overall strength, stability, and sustainability of Oddity’s digital operating model and/or market position; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Oddity class action, go to https://rosenlegal.com/submit-form/?case_id=27381 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

LOS ANGELES, May 11, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Oddity Tech Ltd. (“Oddity” or “the Company”) (NASDAQ: ODD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between February 26, 2025 and February 24, 2026, inclusive (the “Class Period”), are encouraged to contact the firm before May 11, 2026.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Oddity’s advertisements were diverted to poor quality auctions at high costs due to an algorithm change by one of its largest ad partners. The Company’s customer acquisition costs increased significantly due to this change, harming its business. The Company overstates the strength of its operating model. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Oddity, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.        

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

SOURCE:

 The Schall Law Firm

New York, New York--(Newsfile Corp. - May 11, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against ODDITY Tech Ltd. (NASDAQ: ODD) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Oddity securities between February 26, 2025 and February 24, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/ODD.

Oddity Case Details

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose material adverse facts concerning the Company's business, operations, and prospects. Specifically, the Complaint alleges that Defendants failed to disclose that:

following an algorithm change by the Company's largest advertising partner, the Company's advertisements were diverted to lower-quality auctions at abnormally high costs; as a result, the Company's customer acquisition costs increased significantly, negatively impacting its business and financial prospects; Defendants therefore overstated the strength, stability, and sustainability of the Company's digital operating model and market position; and as a result of the foregoing, Defendants' public statements were materially false and misleading at all relevant times.What's Next for Oddity Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/ODD, or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Oddity you have until May 11, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to Oddity Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for Oddity Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Attorney advertising.
Prior results do not guarantee similar outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/295576

Source: Bronstein, Gewirtz & Grossman, LLC

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

SAN FRANCISCO, May 11, 2026 /PRNewswire/ -- Hagens Berman, a global shareholder rights law firm, updates investors in ODDITY Tech Ltd. (NASDAQ: ODD) regarding the pending securities class action lawsuit following a massive 49% stock collapse.

May 15, 2026 09:00 ET  | Source: Oddity Tech Ltd.

NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (“ODDITY”) (NASDAQ: ODD), today announced that it will release its first quarter 2026 financial results before the market open on Tuesday, June 2, 2026, to be followed by a conference call at 8:30 a.m. Eastern Time.

Conference Call Details:

To participate in the conference call, please dial 1-877-407-9208 (US) or 1-201-493-6784 (international). To access the call, please reference the company name and call title: ODDITY First Quarter 2026 Earnings Call. A webcast of the call will be accessible on the Investors section of ODDITY’s website at https://investors.oddity.com. A recording will be available shortly after the conclusion of the call. To access the replay, please dial 1-844-512-2921 (US) or 1-412-317-6671 (international). The access code for the replay is 13760709. An archive of the webcast will be available on the Investors section of ODDITY’s website for seven days following the call.

About ODDITY

ODDITY is a consumer tech company that builds and scales digital-first brands to disrupt the offline-dominated beauty and wellness industries. The company serves approximately 68 million users with its AI-driven online platform, deploying data science to identify consumer needs, and developing solutions in the form of beauty and wellness products. ODDITY owns IL MAKIAGE, SpoiledChild and METHODIQ. The company operates with business headquarters in New York City, an R&D center in Tel Aviv, Israel, and a biotechnology lab in Boston.

Contacts

Press:

[email protected]

Investor:

[email protected]

First quarter net revenue of $197.9 million, down approximately 26% year-over-yearFirst quarter adjusted EBITDA of $(7.0) millionFirst quarter net loss of $(21.4) million and first quarter adjusted net loss of $(9.8) millionStrong liquidity position including cash, cash equivalents and investments of $667.4 million, and aggregate credit facilities of $350 million which remain undrawn NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (NASDAQ: ODD) today announced its financial results for the first quarter ended March 31, 2026.

“We continue to implement our recovery plan to address the account dislocation with our largest advertising partner and we remain hopeful that we are on track for normalization in the second half of this year,” said Oran Holtzman, ODDITY co-founder and CEO. “For many years, our CPA was very stable, with only gradual increases aligned with our industry. In Q1 2026, we saw a severe step-function discontinuity, comparing to historical first quarters, with CPA in some cases reaching levels 2x higher than what we expected. While we continue to navigate this dislocation, we have been working closely with our advertising partner on remediation and we are encouraged by an improvement in IL MAKIAGE CPA this May, which declined an estimated -28% sequentially from April.”

Media Costs

ODDITY is providing additional data on IL MAKIAGE CPA with our largest advertising partner for H1 2022 through May of H1 2026, as the first half is historically the period in which we acquire the majority of our annual new users. We believe this data supports the view that the CPA dislocation is technical in nature, rather than driven by brand health or market saturation.

Prior to 2026, IL MAKIAGE 1H CPA growth was very stable, with yearly increases correlated with our industry.The increase in 2026 is sudden, indicating a dramatic break rather than steady deterioration over time.The breakdown occurred in different markets simultaneously. US, Canada, UK, Australia, Israel — markets with different longevity and saturation levels.A driver of the break is spiking bounce rates. This shows in our view that the issue is with lower quality audiences being served our ads by the algorithm. IL MAKIAGE CPA Index with Largest Advertising Partner, Internal Attribution System

Half-Year

CPA INDEX

YOY % CHG

H122

1.0

H123

1.2

16

%

H124

1.3

14

%

H125

1.5

15

%

H1 through May 26

2.8

83

%

First Quarter 2026 Summary

ODDITY achieved key objectives during the first quarter, including:

Exceeded our first quarter revenue outlook issued February 25, 2026 of an approximately 30% decline.Positive inflection in IL MAKIAGE CPA’s trend in May, reflecting progress resetting our ad account signals.Remediation work in IL MAKIAGE Try Before You Buy, and a shift of 40% of acquisition revenue out of Try Before You Buy and into Buy.A strong start for our newest brand, METHODIQ, which remains on track to deliver year 1 results in-line with those of SpoiledChild.Ongoing development and expansion of the ODDITY Labs molecule discovery platform.Strong liquidity position including cash, cash equivalents and investments of $667.4 million, and aggregate credit facilities of $350 million which remain undrawn. “We are pleased with the progress we see in our remediation work and with our ability to deliver first quarter revenue above our guidance,” said Lindsay Drucker Mann, ODDITY Global CFO. “The CPA dislocation led to a sharp decline in first orders during the quarter, and the loss of these first orders will negatively impact our repeat business across the year. We therefore expect Q2 net revenue will decline between 25 and 30% year-over-year, and hope to see sequential improvement in the second half of 2026.”

Profitability Drivers

Adjusted EBITDA was materially negatively impacted by higher CPA and ODDITY’s decision to spend on acquisition during the quarter, in an effort to remedy the account dislocation. This led to significantly lower revenue generated on like for like media spend. Reduced media efficiency coupled with continued investment in growth initiatives drove meaningful operating expense deleverage.

Gross margin compression in the period was driven in part by product and brand mix and a low single digit decline in average order value (AOV). ODDITY’s remediation activity during the quarter, which included running various tests to try and isolate the dislocation in its advertising account, negatively impacted Q1 margins.

Share Buyback Program

In March 2026, ODDITY’s Board of Directors approved a share buyback program authorizing the repurchase of up to $200 million of the Company’s Class A ordinary shares. The new authorization expires on March 31, 2029 or upon full deployment of the allocated funds, subject to any future modifications by the Board.

ODDITY repurchased approximately 6.1 million Class A ordinary shares during the first quarter for approximately $82.3 million, reducing Class A ordinary shares outstanding by approximately 10.6%. ODDITY exited the first quarter with approximately $167.3 million remaining under the authorization, subject to market conditions, legal and regulatory constraints.

First Quarter Fiscal 2026 Financial Highlights:

Results for the first quarter ended March 31, 2026 are presented below in comparison to the first quarter ended March 31, 2025.

Net revenue was $197.9 million compared to $268.1 million in the first quarter of 2025, a decrease of 26%.Gross profit was $138.0 million compared to $200.8 million in the first quarter of 2025; gross margin was 69.7% compared to 74.9% in the first quarter of 2025.Net loss was $(21.4) million compared to net income of $37.8 million in the first quarter of 2025.Adjusted net loss was $(9.8) million compared to adjusted net income of $41.8 million in the first quarter of 2025.Adjusted EBITDA was $(7.0) million compared to $52.4 million in the first quarter of 2025.Diluted loss per share was $(0.38) for the first quarter of 2026 compared to diluted earnings per share of $0.63 in the first quarter of 2025.Adjusted diluted loss per share was $(0.17) for the first quarter of 2026 compared to adjusted diluted earnings per share of $0.69 in the first quarter of 2025. Financial Outlook:

For the second quarter of 2026, ODDITY expects net revenue to decline between 25 and 30% year-over-year. ODDITY expects Adjusted EBITDA will be between $8 and $10 million.

For the full year 2026, ODDITY expects Adjusted EBITDA to be positive.

Adjusted EBITDA, Adjusted EBITDA margin, Adjusted net (loss) income, Adjusted net (loss) income margin, Adjusted diluted (loss) earnings per share, and free cash flow are non-GAAP financial measures. Please see the sections titled “Non-GAAP Financial Measures” and “Reconciliations of GAAP to Non-GAAP Measures” below for more information regarding ODDITY’s use of non-GAAP financial measures and reconciliations to the most directly comparable GAAP measures. ODDITY has not provided a quantitative reconciliation of its Adjusted EBITDA outlook to the corresponding net income measure because the quantification of certain items included in the calculation of GAAP net income cannot be calculated or predicted at this time without unreasonable efforts. ODDITY is unable to address the probable significance of the unavailable reconciling items, which could have a potentially unpredictable, and potentially significant, impact on its future GAAP financial results.

The financial outlook figures presented above are forward-looking statements that are subject to a variety of assumptions and estimates. Actual results may differ materially from ODDITY’s financial outlook as a result of, among other things, the factors described under “Forward-Looking Statements” below.

Conference Call Details:

A conference call to discuss ODDITY’s Q1 2026 financial and business results and outlook is scheduled for today, June 2, 2026, at 8:30 a.m. ET. To participate, please dial 1-877-407-9208 (US) or 1-201-493-6784 (international). To access the call, please reference the company name and call title: ODDITY First Quarter 2026 Earnings Call. A webcast of the call will be accessible on the Investors section of ODDITY’s website at https://investors.oddity.com. A recording will be available shortly after the conclusion of the call. To access the replay, please dial 1-844-512-2921 (US) or 1-412-317-6671 (international). The access code for the replay is 13760709. An archive of the webcast will be available on the Investors section of ODDITY’s website for seven days following the call.

Non-GAAP Financial Measures:

In addition to the GAAP financial measures set forth in this press release, ODDITY has included the following non-GAAP financial measures: Adjusted EBITDA, Adjusted EBITDA margin, Adjusted net (loss) income, Adjusted net (loss) income margin, Adjusted diluted (loss) earnings per share and free cash flow. ODDITY believes these non-GAAP financial measures provide useful supplemental information to management and investors to help evaluate ODDITY’s business, measure its performance, identify trends, prepare financial projections and make business decisions.

ODDITY defines “Adjusted EBITDA” as net (loss) income before financial income, net, taxes on income, and depreciation and amortization as further adjusted to exclude share-based compensation expense and non-recurring items. “Adjusted EBITDA margin” is defined as Adjusted EBITDA divided by net revenue. ODDITY believes Adjusted EBITDA and Adjusted EBITDA margin are useful for financial and operational decision-making and as a means to evaluate period-to-period comparisons. By excluding certain items that may not be indicative of its recurring core operating results, ODDITY believes that Adjusted EBITDA and Adjusted EBITDA margin provide meaningful supplemental information regarding its performance. In addition, Adjusted EBITDA and Adjusted EBITDA margin are widely used by investors and securities analysts to measure a company’s operating performance without regard to items such as depreciation and amortization, interest expense, and interest income, which can vary substantially from company to company depending on their financing and capital structures and the method by which their assets were acquired.

ODDITY defines “Adjusted net (loss) income” as net (loss) income adjusted for the impact of share-based compensation, non-recurring items, one-time tax gains/losses and the tax effect of non-GAAP adjustments and “Adjusted net (loss) income margin” as Adjusted net (loss) income divided by net revenue. In addition, ODDITY defines “Adjusted diluted (loss) earnings per share” as Adjusted net (loss) income divided by diluted shares outstanding. ODDITY believes the presentations of Adjusted net (loss) income, Adjusted net (loss) income margin, and Adjusted diluted (loss) earnings per share are useful because they are frequently used by analysts, investors and other interested parties to evaluate companies in our industry. Further, ODDITY believes these measures are helpful in highlighting trends in our operating results, because they exclude the impact of items that are outside the control of management or not reflective of our ongoing operations and performance.

ODDITY defines “free cash flow” as net cash (used in) provided by operating activities less purchase of property and equipment.

ODDITY’s non-GAAP financial measures should be considered in addition to, not as a substitute for or in isolation from, its financial results prepared in accordance with U.S. GAAP. Other companies, including companies in our industry, may calculate these measures differently or not at all, which reduces their usefulness as comparative measures.

Reconciliations of non-GAAP financial measures to the most directly comparable GAAP measures are included with the financial tables at the end of this release under the heading “Reconciliations of GAAP to Non-GAAP Measures.”

Forward-Looking Statements:

Certain statements in this press release may constitute “forward-looking” statements and information, within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 that relate to our current expectations and views of future events. In some cases, these forward-looking statements can be identified by words or phrases such as “aim,” “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “goal,” “hope,” “intend,” “may,” “objective,” “plan,” “potential,” “predict,” “project,” “shall,” “should,” “target,” “will,” “seek,” or similar words. The absence of these words does not mean that a statement is not forward-looking. These forward-looking statements address various matters, including ODDITY’s business strategy, market opportunity, ability to deliver superior products and experiences, ability to remedy the dislocation in our customer acquisition costs, potential long-term success and ODDITY’s outlook for the second quarter of 2026 and the full year ending December 31, 2026. These forward-looking statements are subject to risks, uncertainties and assumptions, some of which are beyond our control. In addition, these forward-looking statements reflect our current views with respect to future events and are not a guarantee of future performance. Actual outcomes may differ materially from the information contained in the forward-looking statements as a result of a number of factors, including, without limitation, the following: our ability to maintain the value of our brands; our ability to anticipate and respond to market trends and changes in consumer preferences; our ability to cost-effectively attract new customers (including by responding effectively to changes to algorithm-based bidding systems on key advertising platforms), retain existing customers and maintain or increase sales to those customers; our ability to maintain a strong base of engaged customers and content creators; the loss of suppliers or shortages or disruptions in the supply of raw materials or finished products; our ability to accurately forecast customer demand, manage our inventory, and plan for future expenses; our future rate of growth; competition; the fluctuating cost of raw materials; the illegal distribution and sale by third parties of counterfeit versions of our products or the unauthorized diversion by third parties of our products; changes in, or disruptions to, our shipping arrangements; our ability to manage our growth effectively; a general economic downturn or sudden disruption in business conditions; our ability to successfully introduce and effectively market new brands, or develop and introduce new, innovative, and updated products; foreign currency fluctuations; product returns; our ability to execute on our business strategy; our ability to maintain a high level of customer satisfaction; our ability to comply with and adapt to changes in laws and regulatory requirements applicable to our business, including with respect to regulation of the internet and e-commerce, evolving AI-technology related laws, tax laws, the anti-corruption, trade compliance, anti-money laundering, and terror finance and economic sanctions laws and regulations, consumer protection laws, and data privacy and security laws; failure of our products to comply with quality standards and risks related to product liability claims; trade restrictions; existing and potential tariffs; any data breach or other security incident of our information technology systems, or those of our third-party service providers or cyberattacks; risks related to online transactions and payment methods; any failure to obtain, maintain, protect, defend, or enforce our intellectual property rights; conditions in Israel and the Middle East generally, including as a result of geopolitical conflict; the concentration of our voting power as a result of our dual class structure; our status as a foreign private issuer; and other risk factors set forth in the section titled “Risk Factors” in our Annual Report on Form 20-F filed with the Securities and Exchange Commission on March 17, 2026, and other documents filed with or furnished to the SEC. These statements reflect management’s current expectations regarding future events and operating performance and speak only as of the date of this press release. You should not put undue reliance on any forward-looking statements. Except as required by applicable law, we undertake no obligation to update or revise publicly any forward-looking statements.

About ODDITY:

ODDITY is a consumer tech company that builds and scales digital-first brands to disrupt the offline-dominated beauty and wellness industries. The company serves approximately 68 million users with its AI-driven online platform, deploying data science to identify consumer needs, and developing solutions in the form of beauty and wellness products. ODDITY owns IL MAKIAGE, SpoiledChild and METHODIQ. The company operates with business headquarters in New York City, an R&D center in Tel Aviv, Israel, and a biotechnology lab in Boston.

Contacts:

Press:

[email protected]

Investor:

[email protected]

ODDITY TECH LTD.

CONSOLIDATED STATEMENTS OF INCOME

U.S. dollar in thousands (except per share data)

Three months ended
March 31,

  2026

    2025

  (Unaudited)

Net revenue

$

197,940

  $

268,076

  Cost of revenue

  59,970

    67,228

  Gross profit

  137,970

    200,848

  Selling, general and administrative

  163,460

    158,183

  Operating (loss) income

  (25,490

)

  42,665

  Financial income, net

  (5,306

)

  (2,647

)

(Loss) income before taxes on income

  (20,184

)

  45,312

  Taxes on income

  1,177

    7,481

  Net (loss) income

$

(21,361

)

$

37,831

  Weighted-average number of shares – basic (thousands)

  56,317

    56,003

  Weighted-average number of shares – diluted (thousands)

  56,317

    60,322

  Basic (loss) earnings per share

$

(0.38

)

$

0.68

  Diluted (loss) earnings per share

$

(0.38

)

$

0.63

  ODDITY TECH LTD.

CONSOLIDATED BALANCE SHEETS

U.S. dollar in thousands

March 31,

December 31,

  2026

  2025

(Unaudited)

(Audited)

ASSETS

CURRENT ASSETS:

Cash and cash equivalents

$

     278,597

$

     402,209

Marketable securities

  17,113

  11,170

Trade receivables

  23,313

  16,902

Inventories

  147,976

  135,181

Prepaid expenses and other current assets

  33,089

  36,336

Total current assets

  500,088

  601,798

LONG-TERM ASSETS:

Marketable securities

  371,626

  362,571

Property, plant and equipment, net

  9,986

  10,864

Deferred tax asset, net

  30,299

  27,693

Intangible assets, net

  46,141

  43,582

Goodwill

  64,904

  64,904

Operating lease right-of-use assets

  22,701

  22,311

Other assets

  4,082

  4,069

Total long-term assets

  549,739

  535,994

Total assets

$

     1,049,827

$

     1,137,792

ODDITY TECH LTD.

CONSOLIDATED BALANCE SHEETS

U.S. dollar in thousands

March 31,

December 31,

  2026

  2025

(Unaudited)

(Audited)

LIABILITIES AND SHAREHOLDERS’ EQUITY

CURRENT LIABILITIES:

Trade payables

$

     65,252

$

     75,957

Other accounts payable and accrued expenses

  51,374

  32,869

Operating lease liabilities, current

  6,537

  6,002

Total current liabilities

  123,163

  114,828

LONG-TERM LIABILITIES:

Operating lease liabilities, non-current

  17,260

  17,463

Exchangeable Note

  585,222

  584,368

Other long-term liabilities

  25,272

  24,638

Total liabilities

  750,917

  741,297

SHAREHOLDERS’ EQUITY:

Class A Ordinary shares

  13

  15

Class B Ordinary shares

  3

  3

Additional paid-in capital

  4,230

  77,571

Accumulated other comprehensive income

  2,011

  4,892

Retained earnings

  292,653

  314,014

Total shareholders’ equity

  298,910

  396,495

Total liabilities and shareholders’ equity

$

     1,049,827

$

     1,137,792

ODDITY TECH LTD.

CONSOLIDATED STATEMENTS OF CASH FLOWS

U.S. dollar in thousands

Three months ended March 31,

  2026

    2025

  (Unaudited)

Cash flows from operating activities:

Net (loss) income

$

(21,361

)

$

37,831

  Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:

Depreciation and amortization

  4,269

    2,655

  Share-based compensation

  8,101

    7,084

  Deferred income taxes

  (1,803

)

  (302

)

Amortization of debt issuance costs

  854

    —

  Change in trade receivables

  (6,411

)

  (4,289

)

Change in prepaid expenses and other receivables

  2,772

    (4,631

)

Change in inventories

  (12,795

)

  3,554

  Change in trade payables

  (10,704

)

  41,642

  Change in other accounts payable and accrued expenses

  17,330

    4,903

  Change in operating lease right-of-use assets

  1,943

    1,969

  Change in operating lease liability

  (2,002

)

  (2,049

)

Other

  (427

)

  (31

)

Net cash (used in) provided by operating activities

$

(20,234

)

$

88,336

  Cash flows from investing activities:

Purchase of property, plant and equipment

  (858

)

  (1,002

)

Capitalization of software development costs and investment in other intangible assets

  (4,197

)

  (1,739

)

Investment in marketable securities, net

  (18,435

)

  (1,069

)

Other investing activities

  —

    (151

)

Net cash used in investing activities

  (23,490

)

  (3,961

)

Cash flows from financing activities:

Proceeds from exercise of options

  13

    1,931

  Repurchase and retirement of ordinary shares

  (80,055

)

  —

  Net cash (used in) provided by financing activities

  (80,042

)

  1,931

  Effect of exchange rate fluctuations on cash and cash equivalents

  106

    284

  Net (decrease) increase in cash, cash equivalents and restricted cash

  (123,660

)

  86,590

  Cash, cash equivalents and restricted cash at the beginning of the period

  402,279

    50,347

  Cash, cash equivalents and restricted cash at the end of the period

$

278,619

  $

136,937

  ODDITY TECH LTD.

Reconciliation of GAAP to Non-GAAP Measures

U.S. dollar in thousands (except per share data)

Three months ended
March 31,

  2026

    2025

  (Unaudited)

Reconciliation of Net (Loss) Income and Adjusted EBITDA

Net (loss) income

$

(21,361

)

$

37,831

  Financial income, net

  (5,306

)

  (2,647

)

Taxes on income

  1,177

    7,481

  Depreciation and amortization

  4,269

    2,655

  Share-based compensation

  8,101

    7,084

  Other adjustments1

  6,084

    —

  Adjusted EBITDA

$

                  (7,036

)

$

                 52,404

  Reconciliation of Net (Loss) Income and Adjusted Net (Loss) Income

Net (loss) income

$

(21,361

)

$

37,831

  Share-based compensation

  8,101

    7,084

  Other adjustments1

  6,084

    —

     Tax adjustments2

  (2,608

)

  (3,106

)

Adjusted net (loss) income

$

                 (9,784

)

$

                 41,809

  ¹ Represents costs of certain legal matters and employee actions outside the ordinary course of business. 
2 Represents the tax impact of (a) the reconciling items above and (b) in the first quarter of 2025, other discrete tax items.

Three months ended
March 31,

  2026

    2025

(Unaudited)

Diluted (loss) earnings per share

$

(0.38

)

$

0.63

Adjusted diluted (loss) earnings per share

$

                  (0.17

)

$

                     0.69

Reconciliation of net cash (used in) provided by operating activities to free cash flow Three months ended
March 31,

  2026

    2025

  (Unaudited)

Net cash (used in) provided by operating activities

$

(20,234

)

$

88,336

  Purchase of property and equipment

  (858

)

  (1,002

)

Free cash flow

$

               (21,092

)

$

                 87,334

  ODDITY TECH LTD.

Supplemental Financial Information

U.S. dollar in thousands

Cash, cash equivalents, and investments

March 31,

December 31,

  2026

  2025

(Unaudited)

(Audited)

Cash, restricted cash, and cash equivalents

$

278,619

$

402,279

Marketable securities

  388,739

  373,741

Total cash and investments

$

667,358

$

776,020

Net revenue by sales channel Three months ended
March 31,

  2026

    2025

  (Unaudited)

Online direct-to-consumer

$

193,055

  $

261,053

  Percent of net revenue

  98

%

  97

%

Other (Israel retail, marketing affiliates)

$

4,885

  $

7,023

  Percent of net revenue

  2

%

  3

%

Net Revenue

$

197,940

  $

268,076

  Note: ODDITY does not sell to resellers or distributors. Online direct-to-consumer revenues are generated directly by ODDITY through its online platform only (i.e., ILMAKIAGE.com, SpoiledChild.com, and METHODIQ.com). All revenue in Israel, including revenue generated in stores, online, and from beauty academies, is included in Other.

Oddity Tech Ltd. (ODD) Q1 2026 Earnings Call Transcript

Upcoming presentations at ENDO 2026 highlight Lundbeck's Focused Innovator strategy and continued expansion into rare neuroendocrine diseases with high unmet medical needsThe scientific program showcases Lundbeck's investigational neurohormonal and neuroimmunological targeted therapeutic candidates, asedebart and Lu AG22515, respectively Preliminary Phase II data for asedebart, an investigational anti-adrenocorticotropic hormone (ACTH) monoclonal antibody in Cushing's disease (CD), demonstrate Lundbeck's biomarker-supported approach to evaluating novel therapeutic mechanisms in rare endocrine disordersPreclinical characterization of the CD40L blocker Lu AG22515 will be shared as well as data from a patient study in thyroid eye disease (TED,) reflecting exploratory studies of CD40L modulation in autoimmune disease biology, with potential relevance to neuroinflammation implicated in several neurological and endocrine diseases, /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) today announced that new data will be presented at the 2026 Endocrine Society's Annual Meeting (ENDO), taking place June 13–16 in Chicago, Illinois, U.S. Lundbeck will present preliminary Phase II data for asedebart (Lu AG13909) in CD, reflecting Lundbeck's expansion into neuroendocrine diseases. In addition, preclinical and Phase Ib clinical exploratory findings on Lu AG22515 in patients with TED will be shared, providing insights into the broader therapeutic potential of CD40L pathway modulation across inflammatory and immunological disorders.

"Lundbeck's presence at ENDO 2026 reflects how we have expanded upon our neuroscience heritage in recent years. This involves pursuing biological drug targets within hormonal and immunological signaling pathways that offer the potential to deliver highly differentiated therapeutics for neurological and neuroendocrinology indications with high medical unmet need," said Johan Luthman, EVP and Head of Research & Development at Lundbeck. "Through this approach, we have made significant progress across our rare disease programs, enabling decisive, biomarker-supported patient studies that facilitate early development decisions, as exemplified by our ENDO 2026 scientific program."

Asedebart data provide insight into ACTH neutralization in Cushing's disease

Among the highlights are preliminary Phase II data for asedebart, an investigational anti-adrenocorticotropic hormone (ACTH) monoclonal antibody, being evaluated in adults with CD.

CD is a rare neuroendocrine disorder typically caused by an ACTH-secreting pituitary adenoma, leading to chronic excess cortisol production and substantial physical and neuropsychiatric burden.1,2 While surgery is the standard first-line treatment, many patients experience persistent or recurrent disease despite available pharmacologic options, and significant unmet need remains.

The Phase II data being presented include impact on urinary free cortisol (UFC) levels following individualized dose titration of asedebart, alongside safety and tolerability assessments, supporting further understanding of direct ACTH neutralization in CD.

The CD study builds on earlier Phase I findings in classic congenital adrenal hyperplasia (CAH) (ClinicalTrials.gov: NCT05669950), which showed pharmacodynamic effects on key adrenal steroid biomarkers. The CD data presented at ENDO add to Lundbeck's evaluation of targeting ACTH-driven endocrine conditions with links to brain function — using early clinical and pharmacodynamic evidence to assess therapeutic potential in areas of significant unmet need.

Asedebart has received Orphan Drug Designation (ODD) for CAH in the European Union and the United States as well as ODD in Japan for the treatment of patients with CD and CAH.

Lu AG22515 data provide insight into CD40L pathway biology

At ENDO, Lundbeck will also present preclinical characterization findings for the investigational CD40L blocker Lu AG22515. CD40L is a key immune signaling molecule heavily implicated in a wide range of immune disorders, neurology and potentially endocrine conditions.3 The presentation will describe the inhibitory effect and PK/PD profile of Lu AG22515, including effects on membrane-bound and soluble CD40L, B-cell activation and differentiation, proinflammatory cytokine production and in vivo antibody responses.

Additionally, clinical findings will be presented from an exploratory Phase Ib open label study on AG22515 in TED patients. TED is an autoimmune disorder that can cause proptosis, diplopia, pain, disfigurement and, in severe cases, visual impairment or vision loss.4 The presentation will cover three areas: pharmacodynamic assessments designed to evaluate CD40L pathway engagement, safety and tolerability, and preliminary clinical efficacy in TED, including effects on proptosis and other measures of disease activity. The data further enhance the understanding of CD40L pathway modulation in TED and other CD40L-mediated immune disorders.

Asedebart and Lu AG22515 are investigational drugs not approved for marketing by any regulatory authority worldwide, and the efficacy and safety of both molecules have not been established.

Details of Lundbeck presentations at ENDO 2026

Therapeutic Area

Presentation content

Presentation Type

Reference

Cushing's disease
Asedebart
Lu AG13909

A Phase II, Open-label, Dose-titration Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of the Novel Anti-ACTH Antibody Asedebart in Adults with Cushing's Disease

Oral presentation

Sun 14 June
14:45-15:00 CT
Room W183BC

Thyroid eye disease (TED)
Lu AG22515

Results From a Phase 1b Trial Evaluating CD40-Ligand Blocker Lu AG22515 in Patients with Moderate-to-Severe Thyroid Eye Disease

Oral presentation

Mon 15 June
14:15-14:30 CT
W184ABC

Thyroid eye disease (TED)
Lu AG22515

Preclinical Pharmacokinetic and Pharmacodynamic Profile of Lu AG22515, a CD40-Ligand Blocker in Development for Thyroid Eye Disease

Rapid-fire presentation and poster

Sun 14 June
09:00- 16:00 CT
ENDOExpo;
Poster floor

About Cushing's disease

Cushing's disease is a rare neuro-endocrine disorder caused by a pituitary adenoma that secretes excess ACTH, leading to chronic overproduction of cortisol.1 The condition is associated with significant morbidity and increased mortality, and patients may experience a wide range of physical and neuropsychiatric symptoms.2 First-line treatment is surgical removal of the tumor; however, not all patients are eligible, achieve sustained remission, or benefit fully from current available treatment options, highlighting an ongoing unmet need for effective and well-tolerated therapies.

About asedebart (Lu AG13909)

Asedebart is a humanized anti-ACTH monoclonal antibody designed specifically to recognize ACTH with high affinity. It blocks the binding of ACTH to the melanocortin 2 receptor in the adrenal glands and thereby inhibits the neurohormonal signalling of ACTH. This inhibition causes a decreased secretion of glucocorticoids, mineralocorticoids and androgens from the adrenal glands. 5,6 ACTH plays a key role in the biosynthesis of adrenal steroids7 and is therefore considered a promising therapeutic target in conditions characterized by elevated ACTH levels.6

About thyroid eye disease (TED)

Thyroid eye disease (TED) is a rare autoimmune condition associated with thyroid dysfunction, characterized by inflammation and expansion of retro-orbital tissues. Clinical manifestations include proptosis, double-vision, pain, swelling, and disfigurement, and in severe cases may lead to visual impairment or loss of vision. TED can have a substantial impact on daily functioning, quality of life and psychological wellbeing.4

Current treatments are not optimal for all patients and may be associated with significant adverse effects, highlighting the need for additional therapeutic approaches that target underlying autoimmune disease biology. 4

About Lu AG22515

Lu AG22515 is an investigational CD40L blocker being evaluated in CD40L mediated autoimmune diseases. Lu AG22515 is a recombinant fusion protein that binds CD40 ligand (CD40L) and human serum albumin (HSA) to extend half-life. By blocking the interaction between CD40L and the CD40 receptor, Lu AG22515 is designed to modulate a key immune co-stimulatory pathway involved in B-cell activation, antibody responses and inflammatory signaling.

Contacts
Anders Crillesen
Senior Director, External & Internal Relations
[email protected]
+45 27 79 12 86

Jens Høyer
Vice President, Head of Investor Relations
[email protected]
+45 30 83 45 01

About H. Lundbeck A/S

Lundbeck is a biopharmaceutical company focusing exclusively on brain health. With more than 70 years of experience in neuroscience, we are committed to improving the lives of people with neurological and psychiatric diseases.

Brain disorders affect a large part of the world's population, and the effects are felt throughout society. With the rapidly improving understanding of the biology of the brain, we hold ourselves accountable for advancing brain health by curiously exploring new opportunities for treatments.

As a focused innovator, we strive for our research and development programs to tackle some of the most complex neurological challenges. We develop transformative medicines targeting people for whom there are few or no treatments available, expanding into neuro-specialty and neuro-rare from our strong legacy within psychiatry and neurology.

We are committed to fighting stigma and we act to improve health equity. We strive to create long term value for our shareholders by making a positive contribution to patients, their families, and society as a whole.

Lundbeck has more than 5,000 employees in more than 20 countries and our products are available in more than 80 countries. For additional information, we encourage you to visit our corporate site www.lundbeck.com and connect with us via LinkedIn.

References:

Lacroix A, Feelders RA, Stratakis CA, et al. Lancet. 2015;386(9996):913–927Sharma ST, Nieman LK, Feelders RA. Pituitary. 2015;18(2):188–194Ots HD, Tracz JA, Vinokuroff KE, et al. Int J Mol Sci. 2022;23(8):4115Dhaliwal NK, Razzaq L. Cureus. 2025;17(6):e86483.Lundbeck. Data on fileFeldhaus AL, et al. Endocrinology 2017;158(1):1-8Xing Y, et al. J Endocrinol 2011;209(3):327-35CONTACT:
H. Lundbeck A/S
Ottiliavej 9, 2500 Valby, Denmark
+45 3630 1311
[email protected]

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/h--lundbeck-a-s/r/lundbeck-to-present-new-patient-data-on-neuroendocrine-and-neuroimmunology-programs-at-endo-2026,c4359848

The following files are available for download:

View original content:https://www.prnewswire.com/news-releases/lundbeck-to-present-new-patient-data-on-neuroendocrine-and-neuroimmunology-programs-at-endo-2026-302796359.html

SOURCE H. Lundbeck A/S